Evidence map›Paper›PMID 27306439›Full record

ArticleJournal of cellular and molecular medicine2016

Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway.

Cheng Song, Lujuan He, Jin Zhang, Hong Ma, Xiangning Yuan, Gaoyun Hu, Lijian Tao, Jian Zhang, Jie Meng

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Combatting pulmonary fibrosis withChinese herbal medicines · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Immunobiology of pulmonary fibrosis.Frontiers in immunology · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. [Diazepam alleviates pulmonary fibrosis in mice by inhibiting LPS-induced pyroptosis and inflammationNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2024
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Cheng SongDepartment of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China.
Lujuan HeDepartment of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China.
Jin ZhangDepartment of Nephrology Medicine, Xiangya Hospital, Central South University, Changsha, China.
Hong MaDepartment of Nephrology Medicine, Xiangya Hospital, Central South University, Changsha, China.
Xiangning YuanDepartment of Nephrology Medicine, Xiangya Hospital, Central South University, Changsha, China.
Gaoyun HuPharmaceutical School, Central South University, Changsha, China.
Lijian TaoDepartment of Nephrology Medicine, Xiangya Hospital, Central South University, Changsha, China.
Jian ZhangDepartment of Microbial Infection & Immunity, The Ohio State University, Columbus, OH, USA.
Jie MengDepartment of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China. mengjie@csu.edu.cn.
Central South University · CNXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin (IL)-1β plays an important role in the pathogenesis of idiopathic pulmonary fibrosis. The production of IL-1β is dependent upon caspase-1-containing multiprotein complexes called inflammasomes and IL-1R1/MyD88/NF-κB pathway. In this study, we explored whether a potential anti-fibrotic agent fluorofenidone (FD) exerts its anti-inflammatory and anti-fibrotic effects through suppressing activation of NACHT, LRR and PYD domains-containing protein 3 (NALP3) inflammasome and the IL-1β/IL-1R1/MyD88/NF-κB pathway in vivo and in vitro. Male C57BL/6J mice were intratracheally injected with Bleomycin (BLM) or saline. Fluorofenidone was administered throughout the course of the experiment. Lung tissue sections were stained with haemotoxylin and eosin and Masson's trichrome. Cytokines were measured by ELISA, and α-smooth muscle actin (α-SMA), fibronectin, collagen I, caspase-1, IL-1R1, MyD88 were measured by Western blot and/or RT-PCR. The human actue monocytic leukaemia cell line (THP-1) were incubated with monosodium urate (MSU), with or without FD pre-treatment. The expression of caspase-1, IL-1β, NALP3, apoptosis-associated speck-like protein containing (ASC) and pro-caspase-1 were measured by Western blot, the reactive oxygen species (ROS) generation was detected using the Flow Cytometry, and the interaction of NALP3 inflammasome-associated molecules were measured by Co-immunoprecipitation. RLE-6TN (rat lung epithelial-T-antigen negative) cells were incubated with IL-1β, with or without FD pre-treatment. The expression of nuclear protein p65 was measured by Western blot. Results showed that FD markedly reduced the expressions of IL-1β, IL-6, monocyte chemotactic protein-1 (MCP-1), myeloperoxidase (MPO), α-SMA, fibronectin, collagen I, caspase-1, IL-1R1 and MyD88 in mice lung tissues. And FD inhibited MSU-induced the accumulation of ROS, blocked the interaction of NALP3 inflammasome-associated molecules, decreased the level of caspase-1 and IL-1β in THP-1 cells. Besides, FD inhibited IL-1β-induced the expression of nuclear protein p65. This study demonstrated that FD, attenuates BLM-induced pulmonary inflammation and fibrosis in mice via inhibiting the activation of NALP3 inflammasome and the IL-1β/IL-1R1/MyD88/ NF-κB pathway.

Indexed as

Signal TransductionActinsAnimalsBleomycinCaspase 1Chemokine CCL2Collagen Type IDown-RegulationFibronectinsHumansInflammasomesInterleukin-1betaInterleukin-6LungMaleMice, Inbred C57BL5-methyl-1-(3-fluorophenyl)-2-(1H)-pyridoneActa2 protein, mouseActinsBleomycinCaspase 1Ccl2 protein, mouseChemokine CCL2Collagen Type IFibronectinsInflammasomesInterleukin-1betaInterleukin-6Myeloid Differentiation Factor 88NF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanPeroxidasePyridonesReactive Oxygen SpeciesReceptors, InterleukinUric AcidfluorofenidoneIL-1β/IL-1R1/MyD88/NF-κB pathwayNALP3 inflammasomepulmonary fibrosis

Identifiers

PMID27306439
PMCPMC5082399
OpenAlexW2428842240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.